Renal anemia treatment in chronic kidney disease patients
Not Applicable
- Conditions
- Renal anemia in chronic kidney disease patients
- Registration Number
- JPRN-UMIN000021774
- Lead Sponsor
- Shuuwa General Hospital
- Brief Summary
This research was formulated and promoted by Mr. Michio Kuwabara (M.K.), the research director. However, M.K. moved from Shuuwa General Hospital to another hospital from April 1, 2017 because of personnel change. M.K. asked seven colleagues in Shuuwa General Hospital about intention to continue this research, but no one had the intention for various reasons. Therefore, M.K. had to cancel this research.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients complicated with potential diseases causing anemia such as hemorrhagic disease, hematological disease, or carcinoma.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the incidence of CVEs and the survival rate during ESAs administration in three kinds of ESAs [epoetin(EPO), darbepoetin alpha(DPO), and epoetin beta pegol(EPObp)]
- Secondary Outcome Measures
Name Time Method To compare the frequency of adverse events and degree of increase in hemoglobin (Hb) in three kinds of ESAs (EPO, DPO, and EPObp)